Centurion Clinical Research LLC is categorized under Testing Laboratories in Noblesville, IN and active since 2006.
Centurion Clinical Research LLC was established in 2006, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Testing Laboratories business, which does work in the B2B market, and is classified as a Testing Laboratories, under code number 541380 by the NAICS.
If you are seeking more information, feel free to contact William A Mcginnis at the company’s single location by writing to 6887 Spayside Drive North, Noblesville, Indiana IN 46062 or by phoning (317) 773-9040. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Centurion Clinical Research LLC |
| Contact Person: | William A Mcginnis |
| Address: | 6887 Spayside Drive North, Noblesville, Indiana 46062 |
| Phone Number: | (317) 773-9040 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Testing Laboratories |
| SIC Code: | 8734 |
| NAICS Code: | 541380 |
| Share This Business: |
Centurion Clinical Research LLC was started in 2006 to provide professional Testing Laboratories under the SIC code 8734 and NAICS code 541380. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact William A Mcginnis for inquiries that concern Centurion Clinical Research LLC by calling the company number (317) 773-9040, as your correspondence is most welcome. Additionally, the physical location of the single location of Centurion Clinical Research LLC can be found at the coordinates 40.006661,-86.050577 as well as the street address 6887 Spayside Drive North in Noblesville, Indiana 46062.
For its online presence, you may visit Centurion Clinical Research LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.